Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases.

Etit D, Faquin WC, Gaz R, Randolph G, DeLellis RA, Pilch BZ.

Arch Pathol Lab Med. 2008 Nov;132(11):1767-73. doi: 10.1043/1543-2165-132.11.1767.

PMID:
18976013
2.

Recommendations for reporting C cell pathology of the thyroid.

Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Vierhapper H, Niederle B.

Wien Klin Wochenschr. 2002 Apr 15;114(7):274-8.

PMID:
12089863
3.

Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.

Learoyd DL, Gosnell J, Elston MS, Saurine TJ, Richardson AL, Delbridge LW, Aglen JV, Robinson BG.

Clin Endocrinol (Oxf). 2005 Dec;63(6):636-41.

PMID:
16343097
4.
5.

Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.

Qi XP, Zhao JQ, Du ZF, Yang RR, Ma JM, Fei J, Cheng J, Han JS, Jin HY, Chen ZG, Wang JQ, Yang YP, Ying RB, Chen XL, Liu WT, Zhao Y, Jiang HL, Zhang XN.

Eur J Surg Oncol. 2013 Sep;39(9):1007-12. doi: 10.1016/j.ejso.2013.06.015. Epub 2013 Jul 9.

PMID:
23849459
6.

Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.

Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Haas OA, Vierhapper H, Niederle B.

Am J Surg Pathol. 2001 Oct;25(10):1245-51.

PMID:
11688458
7.

Video-assisted central compartment lymphadenectomy in a patient with a positive RET oncogene: initial experience.

Miccoli P, Elisei R, Donatini G, Materazzi G, Berti P.

Surg Endosc. 2007 Jan;21(1):120-3. Epub 2006 Sep 6.

PMID:
16960675
8.

Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.

González-Yebra B, Medrano ME, Mantilla A, Palma V, Colin C, Hernández DM, Tapia J, Dawson B, Salcedo M.

Endocr Pathol. 2003 Spring;14(1):71-80.

PMID:
12746565
9.

Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.

Schellhaas E, König C, Frank-Raue K, Buhr HJ, Hotz HG.

Surgery. 2009 Nov;146(5):906-12. doi: 10.1016/j.surg.2009.06.007. Epub 2009 Jul 15.

PMID:
19744457
10.

Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.

Skinner MA, DeBenedetti MK, Moley JF, Norton JA, Wells SA Jr.

J Pediatr Surg. 1996 Jan;31(1):177-81; discussion 181-2.

PMID:
8632274
11.

[Prophylactic thyroidectomy in children and young people with hereditary medullary thyroid carcinoma: a Chilean experience].

Ramos C, Ojeda D, Cohn D, Wohllk N.

Rev Med Chil. 2005 Sep;133(9):1029-36. Epub 2005 Nov 9. Spanish.

12.

Early malignant progression of hereditary medullary thyroid cancer.

Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD, Wahl RA, Lamesch P, Raue F, Conte-Devolx B, Dralle H; European Multiple Endocrine Neoplasia (EUROMEN) Study Group.

N Engl J Med. 2003 Oct 16;349(16):1517-25.

13.
14.

C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.

Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Vierhapper H, Haas OA, Niederle B.

Am J Surg Pathol. 1998 Jun;22(6):722-8.

PMID:
9630179
15.

Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.

Moore SW, Appfelstaedt J, Zaahl MG.

J Pediatr Surg. 2007 Feb;42(2):326-32.

PMID:
17270543
16.

Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.

Learoyd DL, Marsh DJ, Richardson AL, Twigg SM, Delbridge L, Robinson BG.

Arch Surg. 1997 Sep;132(9):1022-5.

PMID:
9301617
17.

Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients.

Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB.

Surgery. 2003 Dec;134(6):890-9; discussion 899-901.

PMID:
14668720
18.

The pathology of preclinical medullary thyroid carcinoma.

Ashworth M.

Endocr Pathol. 2004 Fall;15(3):227-31. Review.

PMID:
15640548
19.

Preventive thyroidectomy in patients with hereditary medullary thyroid carcinoma found heterozygote for mutant RET proto-oncogene.

Konstantinou E, Sapsakos Mariolis T, Fotis T, Mitsos A, Restos S, Mamoura K, Soultati A, Elefsiniotis I, Kapellakis G.

Pediatr Endocrinol Rev. 2010 Dec;8(2):108-13. Review. Erratum in: Pediatr Endocrinol Rev. 2011 Dec;9(2):608. Evangelos, Konstantinou [corrected to Konstantinou, Evangelos]; Theodoros, Mariolis S [corrected to Sapsakos Mariolis, Theodoros]; Theofanis, Fotis [corrected to Fotis, Theofanis]; Aristotelis, Mitsos [corrected to Mitsos, Aristotelis]; Stilianos, Restos [corrected to Restos, Stylianos]; Konstantinia, Mamoura [corrected to Mamoura, Konstantina]; Aspasia, Soultati [corrected to Soultati, Aspasia]; Ioannis, Elefsiniotis [corrected to Elefsiniotis, Ioannis]; George, Kapellakis [corrected to Kapellakis, George].

PMID:
21150841
20.

Role of preoperative basal calcitonin levels in the timing of prophylactic thyroidectomy in patients with germline RET mutations.

Lifante JC, Blanchard C, Mirallié E, David A, Peix JL.

World J Surg. 2014 Mar;38(3):576-81. doi: 10.1007/s00268-013-2413-y.

PMID:
24357249

Supplemental Content

Support Center